Aptus Completes First EndoStapling Procedures in Europe

August 6, 2010—Aptus Endosystems, Inc. (Sunnyvale, CA) announced that the Aptus EndoStapling system was used for the first time in Europe to treat patients with aortic aneurysm disease. The company said that it continues to build on its clinical experience in the United States, where 176 patients have been treated and more than 900 EndoStaples have been deployed. The device's helical staple technology enables independent endograft fixation and is designed to approximate suturing in an open surgical anastomosis. 
 

In the European procedures, the Aptus EndoStapling system was used in secondary interventions to repair previously implanted endografts, as well as in de novo aortic aneurysm patients in cases when the surgeon believed that the long-term outcome would be improved with the addition of radial fixation of the endograft with the EndoStaple, the company stated.



Jean-Paul P.M. de Vries, MD, performed the first procedure in Europe.



“With the introduction of the Aptus EndoStapling system, proximal fixation of an endograft will be significantly improved,” commented Dr. de Vries. “Its use has a strong potential to substantially decrease the need for follow-up after endovascular aneurysm repair.”

“The EndoStapling system performed wonderfully,” added Professor Eric Verhoeven, MD, who also conducted one of the initial European cases. “In unfriendly anatomy, I was able to staple a proximal cuff to repair a type I endoleak of an endograft that had tilted.”